FBXO4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.131030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.899800E-01
Normal-vs-Stage2
1.273020E-01
Normal-vs-Stage3
2.879700E-02
Normal-vs-Stage4
5.925600E-02
Stage1-vs-Stage2
3.651000E-01
Stage1-vs-Stage3
5.859800E-02
Stage1-vs-Stage4
4.826200E-01
Stage2-vs-Stage3
1.850370E-01
Stage2-vs-Stage4
8.682400E-01
Stage3-vs-Stage4
1.454560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.031030E-01
Normal-vs-AfricanAmerican
5.276400E-01
Normal-vs-Asian
1.898820E-01
Caucasian-vs-AfricanAmerican
4.840600E-01
Caucasian-vs-Asian
6.166000E-01
AfricanAmerican-vs-Asian
5.366600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.641900E-02
Normal-vs-Female
2.556200E-01
Male-vs-Female
3.348000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.938400E-02
Normal-vs-Age(41-60Yrs)
1.215550E-01
Normal-vs-Age(61-80Yrs)
1.191560E-01
Normal-vs-Age(81-100Yrs)
1.714170E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.666400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.356600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.052800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.251400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.263600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.014000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.249900E-02
Normal-vs-Daily Drinker
3.076400E-01
Normal-vs-Weekly Drinker
6.227400E-01
Normal-vs-Occasional Drinker
4.127600E-02
Normal-vs-Social Drinker
7.771900E-02
Non Drinker-vs-Daily Drinker
2.485000E-01
Non Drinker-vs-Weekly Drinker
1.745430E-01
Non Drinker-vs-Occasional Drinker
6.783400E-01
Non Drinker-vs-Social Drinker
2.223400E-01
Daily Drinker-vs-Weekly Drinker
5.495600E-01
Daily Drinker-vs-Occasional Drinker
4.500400E-01
Daily Drinker-vs-Social Drinker
8.679800E-01
Weekly Drinker-vs-Occasional Drinker
2.584800E-01
Weekly Drinker-vs-Social Drinker
4.740200E-01
Occasional Drinker-vs-Social Drinker
4.455000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.747200E-01
Normal-vs-Grade 2
7.953000E-01
Normal-vs-Grade 3
7.979200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.739800E-01
Grade 1-vs-Grade 3
5.920200E-01
Grade 1-vs-Grade 4
7.747200E-01
Grade 2-vs-Grade 3
9.362200E-01
Grade 2-vs-Grade 4
7.953000E-01
Grade 3-vs-Grade 4
7.979200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.545700E-02
Normal-vs-NonDiabetic
1.327250E-01
Diabetic-vs-NonDiabetic
5.566200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.445400E-01
Normal-vs-NoPancreatitis
1.133770E-01
Pancreatitis-vs-NoPancreatitis
2.095400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.817500E-02
Normal-vs-N1
1.605230E-01
N0-vs-N1
6.258600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.043600E-01
Normal-vs-TP53-NonMutant
2.573400E-01
TP53-Mutant-vs-TP53-NonMutant
7.075000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
